Does RILMENIDINE Cause Malignant neoplasm progression? 5 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Malignant neoplasm progression have been filed in association with RILMENIDINE. This represents 0.6% of all adverse event reports for RILMENIDINE.
5
Reports of Malignant neoplasm progression with RILMENIDINE
0.6%
of all RILMENIDINE reports
5
Deaths
5
Hospitalizations
How Dangerous Is Malignant neoplasm progression From RILMENIDINE?
Of the 5 reports, 5 (100.0%) resulted in death, 5 (100.0%) required hospitalization, and 5 (100.0%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RILMENIDINE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does RILMENIDINE Cause?
Acute kidney injury (214)
Lactic acidosis (121)
Fall (120)
Hyperkalaemia (86)
Hypotension (85)
Hypoglycaemia (59)
Diarrhoea (49)
Bradycardia (45)
Rhabdomyolysis (44)
Drug ineffective (41)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which RILMENIDINE Alternatives Have Lower Malignant neoplasm progression Risk?
RILMENIDINE vs RILONACEPT
RILMENIDINE vs RILPIVIRINE
RILMENIDINE vs RILUZOLE
RILMENIDINE vs RIMABOTULINUMTOXINB
RILMENIDINE vs RIMEGEPANT